{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:37:15Z","timestamp":1780472235297,"version":"3.54.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:00:00Z","timestamp":1766707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:00:00Z","timestamp":1766707200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s10157-025-02810-9","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T09:59:47Z","timestamp":1766743187000},"page":"507-517","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Hypomagnesemia in peritoneal and hybrid dialysis: prevalence, predictors, and association with atrial fibrillation"],"prefix":"10.1007","volume":"30","author":[{"given":"Kenji","family":"Nakata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsunori","family":"Toida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4127-7500","authenticated-orcid":false,"given":"Noriaki","family":"Kurita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Hanafusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiko","family":"Joki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,26]]},"reference":[{"key":"2810_CR1","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1159\/000514148","volume":"51","author":"F Zhang","year":"2022","unstructured":"Zhang F, Wu X, Wen Y, Zhan X, Peng FF, Wang X, et al. Hypomagnesemia is a risk factor for cardiovascular disease- and noncardiovascular disease-related mortality in peritoneal dialysis patients. Blood Purif. 2022;51:23\u201330. https:\/\/doi.org\/10.1159\/000514148.","journal-title":"Blood Purif"},{"key":"2810_CR2","doi-asserted-by":"publisher","first-page":"e0152488","DOI":"10.1371\/journal.pone.0152488","volume":"11","author":"K Cai","year":"2016","unstructured":"Cai K, Luo Q, Dai Z, Zhu B, Fei J, Xue C, et al. Hypomagnesemia is associated with increased mortality among peritoneal dialysis patients. PLoS ONE. 2016;11:e0152488. https:\/\/doi.org\/10.1371\/journal.pone.0152488.","journal-title":"PLoS ONE"},{"key":"2810_CR3","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1017\/S0007114518001599","volume":"120","author":"H Ye","year":"2018","unstructured":"Ye H, Cao P, Zhang X, Lin J, Guo Q, Mao H, et al. Serum magnesium and cardiovascular mortality in peritoneal dialysis patients: a 5-year prospective cohort study. Br J Nutr. 2018;120:415\u201323. https:\/\/doi.org\/10.1017\/S0007114518001599.","journal-title":"Br J Nutr"},{"key":"2810_CR4","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.xkme.2020.10.010","volume":"3","author":"L Negrea","year":"2021","unstructured":"Negrea L, DeLozier SJ, Janes JL, Rahman M, Dobre M. Serum magnesium and cardiovascular outcomes and mortality in CKD: the Chronic Renal Insufficiency Cohort (CRIC). Kidney Med. 2021;3:183-192.e1. https:\/\/doi.org\/10.1016\/j.xkme.2020.10.010.","journal-title":"Kidney Med"},{"key":"2810_CR5","doi-asserted-by":"publisher","DOI":"10.1159\/000536595","author":"T Toida","year":"2024","unstructured":"Toida T, Kurita N, Abe M, Norio H, Joki N. Impact of dysmagnesemia on atrial fibrillation in maintenance hemodialysis patients: a nationwide study. Cardiorenal Med. 2024. https:\/\/doi.org\/10.1159\/000536595.","journal-title":"Cardiorenal Med"},{"key":"2810_CR6","doi-asserted-by":"publisher","first-page":"e34301","DOI":"10.34172\/jrip.2024.34301","volume":"14","author":"S Ravanshad","year":"2025","unstructured":"Ravanshad S, Mohammadian M, Taherynejad M, Lotfi Z, Emadzadeh M, Miri M. Serum magnesium level in peritoneal dialysis patients. J Renal Inj Prev. 2025;14:e34301. https:\/\/doi.org\/10.34172\/jrip.2024.34301.","journal-title":"J Renal Inj Prev"},{"key":"2810_CR7","doi-asserted-by":"publisher","first-page":"450","DOI":"10.3747\/pdi.2012.00164","volume":"33","author":"H Ye","year":"2013","unstructured":"Ye H, Zhang X, Guo Q, Huang N, Mao H, Yu X, et al. Prevalence and factors associated with hypomagnesemia in Southern Chinese continuous ambulatory peritoneal dialysis patients. Perit Dial Int. 2013;33:450\u20134. https:\/\/doi.org\/10.3747\/pdi.2012.00164.","journal-title":"Perit Dial Int"},{"key":"2810_CR8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1177\/089686089501500112","volume":"15","author":"AA Ejaz","year":"1995","unstructured":"Ejaz AA, McShane AP, Gandhi VC, Leehey DJ, Ing TS. Hypomagnesemia in continuous ambulatory peritoneal dialysis patients dialyzed with a low-magnesium peritoneal dialysis solution. Perit Dial Int. 1995;15:61\u20134. https:\/\/doi.org\/10.1177\/089686089501500112.","journal-title":"Perit Dial Int"},{"key":"2810_CR9","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1177\/089686080902900511","volume":"29","author":"H Eddington","year":"2009","unstructured":"Eddington H, Hurst H, Ramli MT, Speake M, Hutchison AJ. Calcium and magnesium flux in automated peritoneal dialysis. Perit Dial Int. 2009;29:536\u201341. https:\/\/doi.org\/10.1177\/089686080902900511.","journal-title":"Perit Dial Int"},{"key":"2810_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s41100-020-00286-9","volume":"6","author":"K Nitta","year":"2020","unstructured":"Nitta K, Goto S, Masakane I, Hanafusa N, Taniguchi M, Hasegawa T, et al. Annual dialysis data report for 2018, JSDT Renal Data Registry: survey methods, facility data, incidence, prevalence, and mortality. Ren Replace Ther. 2020;6:41. https:\/\/doi.org\/10.1186\/s41100-020-00286-9.","journal-title":"Ren Replace Ther"},{"key":"2810_CR11","doi-asserted-by":"publisher","first-page":"579","DOI":"10.4009\/jsdt.53.579","volume":"53","author":"K Nitta","year":"2020","unstructured":"Nitta K, Masakane I, Hanafusa N, Hoshino J, Taniguchi M, Joki N, et al. 2019 annual dialysis data report JSDT renal data registry. J Jpn Soc Dial Ther. 2020;53:579\u2013632. https:\/\/doi.org\/10.4009\/jsdt.53.579.","journal-title":"J Jpn Soc Dial Ther"},{"key":"2810_CR12","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1016\/j.chest.2020.03.011","volume":"158","author":"M Etminan","year":"2020","unstructured":"Etminan M, Collins GS, Mansournia MA. Using causal diagrams to improve the design and interpretation of medical research. Chest. 2020;158:S21\u20138. https:\/\/doi.org\/10.1016\/j.chest.2020.03.011.","journal-title":"Chest"},{"key":"2810_CR13","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1097\/EDE.0b013e318225c2be","volume":"22","author":"J Textor","year":"2011","unstructured":"Textor J, Hardt J, Kn\u00fcppel S. DAGitty: a graphical tool for analyzing causal diagrams. Epidemiology. 2011;22:745. https:\/\/doi.org\/10.1097\/EDE.0b013e318225c2be.","journal-title":"Epidemiology"},{"key":"2810_CR14","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1002\/sim.4780100410","volume":"10","author":"DB Rubin","year":"1991","unstructured":"Rubin DB, Schenker N. Multiple imputation in health-care databases: an overview and some applications. Stat Med. 1991;10:585\u201398. https:\/\/doi.org\/10.1002\/sim.4780100410.","journal-title":"Stat Med"},{"issue":"1","key":"2810_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000496217","volume":"47","author":"G Li","year":"2019","unstructured":"Li G, Zhang L, Ren H, Huang B, Mao C, Zhou A. Clearance of magnesium in peritoneal dialysis patients: a single-center study. Blood Purif. 2019;47(1):1\u20137. https:\/\/doi.org\/10.1159\/000496217.","journal-title":"Blood Purif"},{"key":"2810_CR16","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1093\/ckj\/sfv097","volume":"8","author":"N Kurita","year":"2015","unstructured":"Kurita N, Akizawa T, Fukagawa M, Onishi Y, Kurokawa K, Fukuhara S. Contribution of dysregulated serum magnesium to mortality in hemodialysis patients with secondary hyperparathyroidism: a 3-year cohort study. Clin Kidney J. 2015;8:744\u201352. https:\/\/doi.org\/10.1093\/ckj\/sfv097.","journal-title":"Clin Kidney J"},{"key":"2810_CR17","doi-asserted-by":"publisher","first-page":"181","DOI":"10.5414\/CN110115","volume":"94","author":"C Holzmann-Littig","year":"2020","unstructured":"Holzmann-Littig C, McCallum W, Heemann U, Renders L, Bietenbeck A, Steubl D. Peritoneal magnesium elimination and its clinical relevance in peritoneal dialysis patients. Clin Nephrol. 2020;94:181\u20136. https:\/\/doi.org\/10.5414\/CN110115.","journal-title":"Clin Nephrol"},{"key":"2810_CR18","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/s0008-6363(01)00529-6","volume":"54","author":"RF Bosch","year":"2002","unstructured":"Bosch RF, Nattel S. Cellular electrophysiology of atrial fibrillation. Cardiovasc Res. 2002;54:259\u201369. https:\/\/doi.org\/10.1016\/s0008-6363(01)00529-6.","journal-title":"Cardiovasc Res"},{"key":"2810_CR19","doi-asserted-by":"publisher","first-page":"6250312","DOI":"10.1155\/2017\/6250312","volume":"2017","author":"S Mawri","year":"2017","unstructured":"Mawri S, Gildeh E, Joseph N, Rabbani B, Zweig B. Cardiac dysrhythmias and neurological dysregulation: manifestations of profound hypomagnesemia. Case Rep Cardiol. 2017;2017:6250312. https:\/\/doi.org\/10.1155\/2017\/6250312.","journal-title":"Case Rep Cardiol"},{"key":"2810_CR20","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1002\/cphy.c140047","volume":"5","author":"J Pellman","year":"2015","unstructured":"Pellman J, Sheikh F. Atrial fibrillation: mechanisms, therapeutics, and future directions. Compr Physiol. 2015;5:649\u201365. https:\/\/doi.org\/10.1002\/cphy.c140047.","journal-title":"Compr Physiol"},{"key":"2810_CR21","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.athoracsur.2004.06.062","volume":"79","author":"H Kohno","year":"2005","unstructured":"Kohno H, Koyanagi T, Kasegawa H, Miyazaki M. Three-day magnesium administration prevents atrial fibrillation after coronary artery bypass grafting. Ann Thorac Surg. 2005;79:117\u201326. https:\/\/doi.org\/10.1016\/j.athoracsur.2004.06.062.","journal-title":"Ann Thorac Surg"},{"key":"2810_CR22","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1080\/08860220701392215","volume":"29","author":"P Amirmokri","year":"2007","unstructured":"Amirmokri P, Morgan P, Bastani B. Intra-peritoneal administration of potassium and magnesium: a practical method to supplement these electrolytes in peritoneal dialysis patients. Ren Fail. 2007;29:603\u20135. https:\/\/doi.org\/10.1080\/08860220701392215.","journal-title":"Ren Fail"},{"key":"2810_CR23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1161\/CIRCULATIONAHA.111.082511","volume":"127","author":"AM Khan","year":"2013","unstructured":"Khan AM, Lubitz SA, Sullivan LM, Sun JX, Levy D, Vasan RS, et al. Low serum magnesium and the development of atrial fibrillation in the community: the Framingham heart study. Circulation. 2013;127:33\u20138. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.082511.","journal-title":"Circulation"},{"key":"2810_CR24","doi-asserted-by":"publisher","first-page":"14982","DOI":"10.1038\/s41598-023-42187-x","volume":"13","author":"M Hori","year":"2023","unstructured":"Hori M, Yasuda K, Takahashi H, Morozumi K, Maruyama S. The association of low serum magnesium levels with frailty among hemodialysis patients. Sci Rep. 2023;13:14982. https:\/\/doi.org\/10.1038\/s41598-023-42187-x.","journal-title":"Sci Rep"},{"key":"2810_CR25","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.1093\/eurheartj\/ehab597","volume":"42","author":"MP Bonnesen","year":"2021","unstructured":"Bonnesen MP, Frodi DM, Haugan KJ, Kronborg C, Graff C, H\u00f8jberg S, et al. Day-to-day measurement of physical activity and risk of atrial fibrillation. Eur Heart J. 2021;42:3979\u201388. https:\/\/doi.org\/10.1093\/eurheartj\/ehab597.","journal-title":"Eur Heart J"},{"key":"2810_CR26","doi-asserted-by":"publisher","first-page":"ehaf881","DOI":"10.1093\/eurheartj\/ehaf881","volume":"4","author":"Y Yin","year":"2025","unstructured":"Yin Y, Costello RB, Fonarow GC, Heidenreich PA, Morgan CJ, Faselis C, et al. Oral magnesium and outcomes in US veterans with heart failure. Eur Heart J. 2025;4:ehaf881. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf881.","journal-title":"Eur Heart J"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-025-02810-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-025-02810-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-025-02810-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T08:11:44Z","timestamp":1772266304000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-025-02810-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,26]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["2810"],"URL":"https:\/\/doi.org\/10.1007\/s10157-025-02810-9","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,26]]},"assertion":[{"value":"10 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"TT has received consulting fees from Astellas Pharma Inc. He has also honoraria for speaking engagements and educational events from Torii Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., Kyowa Kirin Co.,Ltd., AstraZeneca K.K. Kissei Pharmaceutical Co., Ltd., and Nobelpharma Co., Ltd. NK has received consulting fees from GlaxoSmithKline K.K. and Kyowa Kirin Co., Ltd. He has also received honoraria for speaking engagements and educational events from Eisai Co., Ltd., Taisho Pharmaceutical Co., Ltd., Kyowa Kirin Co., Ltd., GlaxoSmithKline K.K., Takeda Pharmaceutical Co., Ltd., Kissei Pharmaceutical Co., Ltd., and Vantive Japan. MA has received payment for speaking from Novartis Pharma K.K., Otsuka Pharmaceutical. The other authors declared no potential conflicts of interest with respect to the research, authorship, and publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All data were de-identified prior to analysis. This study was conducted in accordance with the Act on the Protection of Personal Information in Japan, the Ethical Guidelines for Epidemiological Research issued by the Ministry of Education, Culture, Sports, Science and Technology and the Ministry of Health, Labour and Welfare, and the STROBE guidelines. The study protocol was approved by the Ethics Committee of the Japanese Society for Dialysis Therapy (approval number 56).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The data used in this study contained no identifying personal information. The requirement for informed consent was waived by the Medicine Ethics Committee of the JSDT.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}